NCT02978534View on ClinicalTrials.gov

Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2020

Study Completion Date

December 31, 2020

Conditions
Bipolar Disorder
Interventions
DRUG

Quetiapine

Quetiapine concentrations will be observed in women who have already (under the guidance of a physician) decided to continue taking Quetiapine for the treatment of Bipolar Disorder (any subtype) or Schizophrenia during pregnancy.

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02978534 - Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum | Biotech Hunter | Biotech Hunter